Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Foundation Healthcare Holdings IPO: The Biggest SGX Healthcare Listing Since IHH — Worth Chasing?

Special Edition: Foundation Healthcare IPO Singapore hasn't seen a healthcare IPO of this size in over a decade. Foundation Healthcare Holdings (" FHH ") is looking to raise up to S$242 million at an offering price of S$0.76 per share , implying a market capitalisation of roughly S$1.0 billion — reportedly the largest healthcare listing on SGX since IHH Healthcare's dual-listing back in 2012. Public offer closes 6 July, 12pm , with trading expected to start on 8 July 2026 . Let's dig into what FHH actually does, why parts of the story are genuinely attractive, where I'd want to be careful, and whether the pricing leaves anything on the table for IPO subscribers. The Business: A Doctor Roll-Up With a Tech Layer FHH is a multi-specialty private healthcare platform built on three verticals: Specialists — 108 full-time medical specialists across 16 specialties and 74 specialist clinics as at 31 March 2026, making...

AGV Group Limited



AGV Group Limited ("AGV Group" or the "Company") is offering 26.92m shares via placement at $0.22 each, comprising 21.82m new shares and 5.1m vendor shares for a listing on Catalist. The offer will close on 24 August 2016 at 12pm. The market cap based on the IPO price is S$27.7m.

I don't intend to spend too much time on this IPO as all the shares are placed via placement.

The Company is one of the leading providers of hot dip galvanizing services in Singapore to steel and iron fabrication industries with a well diversified client base.

According to the prospectus, the competitive strengths are as follows:
  • market quality services at competitive prices
  • attuned to customers' needs
  • experienced and management team
  • established business relationships and extensive networks
Financial Results


While the revenue is growing steadily, this is still a small cap company with revenue of less than $20m. The first half profit for FY2016 is actually lower than that of FY2015.

Based on the EPS (post-placement share cap) of 1.78 and assuming the service agreement is in place, the IPO is priced at a PER of 16.6x. This is not exactly "value for money" in Singapore context. 

Some of my concerns include:
  • This is a small cap company with revenue less than $20m and in a competitive industry
  • Vendors are cashing out at the IPO
  • There is a long list of pre-ipo investors who invested at around 8.8 cents who may want to exit
  • The listing valuation at 16x historical is not exactly compelling
  • The current IPO sentiments and climate is weak
For the above reasons and given there is no public tranche, i will give it a zero rating.

Happy IPOing

Comments

Anonymous said…
Based on the price of 0.22 and EPS of 1.78, wouldn't the PER be 12x rather than 16x? Sorry newbie question.
Dennis Ng said…
Look like the Fullerton Healthcare IPO has stalled.
http://www.businesstimes.com.sg/companies-markets/fullerton-healthcare-said-to-delay-ipo-after-regulatory-queries
Unknown said…
Will you write on the new ipo HC surgical
Unknown said…
mr ipo why no answer de
Mr. IPO said…
Over weekend la. No public tranche